The SPORT trial (Single Pre-Operative Radiation Therapy for low-risk breast cancer) investigated residual disease burden and immunological responses following single-dose preoperative radiotherapy in women ≥ 60 years with ER+/HER2− T1N0 breast cancers surgically treated with partial mastectomy and sentinel lymph node biopsy. This evidence concerns the gene ESR1 and breast carcinoma.